Assembly Biosciences, Inc.
ASMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $28,520 | $7,163 | $0 | $6,254 |
| % Growth | 298.2% | – | -100% | – |
| Cost of Goods Sold | $0 | $48,900 | $69,080 | $0 |
| Gross Profit | $28,520 | -$41,737 | -$69,080 | $6,254 |
| % Margin | 100% | -582.7% | – | 100% |
| R&D Expenses | $55,933 | $48,900 | $69,980 | $68,524 |
| G&A Expenses | $18,007 | $22,909 | $23,934 | $28,780 |
| SG&A Expenses | $18,007 | $22,909 | $23,934 | $28,780 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$48,900 | -$68,880 | $41,638 |
| Operating Expenses | $73,940 | $22,909 | $25,034 | $138,942 |
| Operating Income | -$45,420 | -$64,646 | -$94,114 | -$132,688 |
| % Margin | -159.3% | -902.5% | – | -2,121.7% |
| Other Income/Exp. Net | $5,573 | $3,451 | $1,022 | $302 |
| Pre-Tax Income | -$39,847 | -$61,195 | -$93,092 | -$132,386 |
| Tax Expense | $330 | $33 | $0 | -$2,531 |
| Net Income | -$40,177 | -$61,228 | -$93,092 | -$129,855 |
| % Margin | -140.9% | -854.8% | – | -2,076.4% |
| EPS | -6.69 | -13.38 | -22.82 | -36 |
| % Growth | 50% | 41.4% | 36.6% | – |
| EPS Diluted | -6.69 | -13.38 | -22.82 | -36 |
| Weighted Avg Shares Out | 6,005 | 4,577 | 4,034 | 3,607 |
| Weighted Avg Shares Out Dil | 6,005 | 4,577 | 4,034 | 3,607 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,573 | $3,451 | $1,022 | $302 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $129 | $450 | $498 | $466 |
| EBITDA | -$45,291 | -$64,196 | -$92,516 | -$90,584 |
| % Margin | -158.8% | -896.2% | – | -1,448.4% |